PWMG
DSGN icon

Private Wealth Management Group’s Design Therapeutics DSGN Stock Holding History

Private Wealth Management Group’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.67K Sell
533
-25
-4% -$253 ﹤0.01% 724
2025
Q4 		$5.24K Hold
558
– – ﹤0.01% 750
2025
Q3 		$4.2K Hold
558
– – ﹤0.01% 863
2025
Q2 		$1.88K Hold
558
– – ﹤0.01% 1101
2025
Q1 		$2.15K Hold
558
– – ﹤0.01% 1027
2024
Q4 		$3.44K Hold
558
– – ﹤0.01% 892
2024
Q3 		$3K Hold
558
– – ﹤0.01% 920
2024
Q2 		$1.87K Hold
558
– – ﹤0.01% 1072
2024
Q1 		$2.25K Buy
+558
New +$1.49K ﹤0.01% 913

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Private Wealth Management Group's DSGN Position: Q1 2026 in Review

Private Wealth Management Group reduced its Design Therapeutics (DSGN) stake by 4.5% in Q1 2026, selling an estimated $253 and leaving 533 shares worth $5.67K. The position accounts for ﹤0.01% of the portfolio, ranked #724.

Private Wealth Management Group first reported a position in DSGN in Q1 2024 and has held it in 9 quarters since. 125 funds tracked by Wall St. Rank hold DSGN as of Q1 2026.

  • Private Wealth Management Group held 533 shares of Design Therapeutics worth $5.67K as of Q1 2026.
  • Private Wealth Management Group sold 25 Design Therapeutics shares in Q1 2026, an estimated $253.
  • Design Therapeutics made up ﹤0.01% of Private Wealth Management Group's portfolio in Q1 2026, its #724 holding.
  • Private Wealth Management Group first reported a position in Design Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • 125 funds tracked by Wall St. Rank held Design Therapeutics as of Q1 2026.

Based on Private Wealth Management Group's 13F filing for Q1 2026, filed 23 Apr 2026.